نتایج جستجو برای: mesalamine

تعداد نتایج: 1014  

Journal: :Indian Journal of Pharmaceutical Education and Research 2021

Abstract: Background: Inflammatory bowel disease (IBD) is a chronic inflammatory of large intestine consisting ulcerative colitis and Crohn’s disease. Mesalamine first line drug use for the treatment but it has drawback low water solubility permeability. In addition, oral delivery to colon faces problem gastric degradation thus increases dose size frequency. Objectives: The present study was ai...

Journal: :Journal of Drug Delivery and Therapeutics 2022

Mesalamine is a gold standard anti-inflammatory drug used to treat inflammatory bowel illnesses. It's usually and keep Ulcerative Colitis in remission mild moderate cases. rapidly cleared from circulation after being consumed orally, with an elimination half-life of only one hour. Oral intake delayed or slow released matrix formulations can acquire therapeutic concentration the intestines. The ...

2016
Carmen Cuffari David Pierce Bartosz Korczowski Krzysztof Fyderek Heather Van Heusen Stuart Hossack Hong Wan Alena YZ Edwards Patrick Martin

BACKGROUND Limited data are available on mesalamine (5-aminosalicylic acid; 5-ASA) use in pediatric ulcerative colitis (UC). AIM To evaluate pharmacokinetic and safety profiles of 5-ASA and metabolite acetyl-5-ASA (Ac-5-ASA) after once-daily, oral administration of multimatrix mesalamine to children and adolescents with UC. METHODS Participants (5-17 years of age; 18-82 kg, stratified by we...

2014
Harland S. Winter Piotr Krzeski Melvin B. Heyman Eduardo Ibarguen-Secchia Barbara Iwanczak Maciej Kaczmarski Jaroslaw Kierkus Sanja Kolaček Bankole Osuntokun J. Antonio Quiros Manoj Shah Bruce Yacyshyn Preston M. Dunnmon

OBJECTIVE The aim of the study was to assess the safety and efficacy of high- and low-dose oral, delayed-release mesalamine in a randomized, double-blind, active control study of children with mild-to-moderately active ulcerative colitis. METHODS Patients ages 5 to 17 years, with a Pediatric Ulcerative Colitis Activity Index (PUCAI) score of ≥ 10 to ≤ 55 and a truncated Mayo Score of ≥ 1 for ...

Journal: :American Journal of Gastroenterology 2019

2004
Ian R Wilding Atul Sinha Denise J. Ball Alyson L. Connor Jeremy Nightingale Ian R. Wilding

56 INTRODUCTION Inflammatory bowel disease (IBD) is a collective term for the two conditions: Crohn’s disease and ulcerative colitis. Crohn’s disease is a transmural inflammatory disease that can affect the small intestine only (30%), the colon only (25%), or both the small intestine and the colon at the same time (40%). Ulcerative colitis is an inflammatory disease of the colonic mucosa with n...

Journal: :The Journal of pharmacology and experimental therapeutics 2006
Eleonora Distrutti Luca Sediari Andrea Mencarelli Barbara Renga Stefano Orlandi Giuseppe Russo Giuseppe Caliendo Vincenzo Santagada Giuseppe Cirino John L Wallace Stefano Fiorucci

H(2)S functions as a neuromodulator and exerts anti-inflammatory activities. Recent data indicate that irritable bowel syndrome (IBS) is linked to inflammation of the gastrointestinal tract. In this study, we have investigated the role of a novel H(2)S-releasing derivative of mesalamine (5-amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester, ATB-429) in modulating nocicept...

Journal: :Therapeutics and Clinical Risk Management 2007
Raffi Karagozian Robert Burakoff

Ulcerative colitis (UC) is a chronic inflammatory condition of unclear etiology affecting the large bowel, most commonly the rectum and extending proximally in a continuous fashion. The overall principle in the pathophysiolgy of ulcerative colitis is the dysregulation of the normal immune system against an antigenic trigger leading to a prolonged mucosal inflammatory response. The diagnosing of...

2006
Eleonora Distrutti Luca Sediari Andrea Mencarelli Barbara Renga Stefano Orlandi Giuseppe Russo Giuseppe Caliendo Vincenzo Santagada Giuseppe Cirino John L. Wallace Stefano Fiorucci Enrico Dal Pozzo

Hydrogen sulfide (H2S) functions as a neuromodulator and exerts anti-inflammatory activities. Recent data indicate that irritable bowel syndrome (IBS) is linked to inflammation of the gastrointestinal tract. In this study we have investigated the role of a novel H2Sreleasing derivative of mesalamine (ATB-429) in modulating nociception to colorectal distension (CRD), a model that mimics some fea...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید